drugset / Trial / NCT07235046
A Study of DII235 in Adults With Elevated Lipoprotein(a)
RandomizedParallel-groupDouble-blindTreatment
Summary
The main purpose of this study is to determine the safety and efficacy of DII235 in adults with elevated lipoprotein(a).
Timeline
- Start
- 2025-12-02
- Primary completion
- 2027-04-26
- Completion
- 2028-04-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DII235 | Unknown | — | — |
Indications
No indication recorded.